Business Hours: Monday - Friday: 9 AM - 6 PM EST
David Fuller
Last Updated On: May 9, 2025
The global demand for facial enhancement treatments continues to grow, with more individuals opting for non-surgical procedures that offer gradual and natural-looking results. This shift has increased interest in advanced injectables that prioritize skin quality, structural support, and long-term improvement.
Lanluma is one such treatment gaining attention. As a poly-L-lactic acid (PLLA) collagen stimulator, it differs from traditional dermal fillers by encouraging the body’s own collagen production rather than providing immediate volume alone. This approach supports subtle facial contouring and progressive rejuvenation over time.
This article will examine how Lanluma works for facial enhancement, its benefits, and the important considerations patients and practitioners should be aware of before starting treatment.
About: Operating since 2016, Med Supply Solutions is known for being one of the industry’s top and trusted suppliers of cosmetic and viscosupplementation products. Contact our sales department for more information about buying Lanluma Fillers online.
$229.00
Tier pricing
Save 0.87%
3 or more
$227.00 each
Save 1.31%
11 or more
$226.00 each
Save 1.75%
21 or more
$225.00 each
Lanluma contains poly-L-lactic acid (PLLA), a biocompatible and biodegradable compound that medical professionals have safely used in medical applications for decades. When injected into the dermal and subdermal layers of the skin, the PLLA particles form a supportive matrix that stimulates fibroblasts—the cells responsible for producing collagen. This stimulation triggers a biological process known as collagen neogenesis, resulting in a gradual increase in dermal thickness and overall skin structure improvement.
Unlike traditional fillers that deliver immediate but short-lived results, Lanluma promotes progressive volumization by encouraging the body’s own collagen production. This natural regeneration process ensures that the aesthetic changes unfold gradually, making the enhancement more subtle and long-lasting.
Lanluma is commonly used for various facial volume restoration procedures. It is effective in addressing areas affected by age-related collagen loss or volume depletion:
Clinicians customize each treatment based on the patient’s needs and facial anatomy, allowing for a tailored approach to non-surgical facial rejuvenation.
Administering Lanluma requires a refined understanding of facial anatomy and collagen behavior. Practitioners often use fine-gauge needles or blunt-tip cannulas to place the product precisely within targeted facial planes. Providers select the injection depth and volume according to the specific treatment goals.
Following injection, practitioners typically massage the treated areas to promote even distribution and reduce the chance of nodule formation. Patients receive instructions to gently massage the treated area at home for several days. This activates the collagen-stimulating processes and enhances results.
Some patients may ask, “Is Lanluma FDA approved?“ While it currently carries CE certification for use in Europe, it has not yet received FDA approval in the United States. This makes it important for patients in FDA-regulated markets to consult their practitioners for alternative options or to understand the regulatory landscape.
The results of Lanluma facial treatments unfold in a phased manner:
This steady progression helps ensure a natural-looking transformation and aligns well with patient expectations for subtle facial enhancement.
Lanluma is gaining recognition as an effective, non-surgical option for those seeking facial rejuvenation. By activating the skin’s natural ability to produce collagen, it delivers gradual, long-lasting results that preserve facial harmony without the need for invasive surgery.
A consultation with a qualified practitioner is essential to assess suitability, address safety concerns, and determine whether Lanluma is the right choice for your aesthetic goals.
Most patients require 2 to 3 sessions, spaced 4 to 6 weeks apart, depending on the treatment area and desired results.
Currently, Lanluma is not FDA-approved for use in the United States. However, it holds a CE mark in Europe, indicating compliance with European health, safety, and environmental protection standards.
Common side effects include tenderness, redness, bruising, and swelling at the injection site. These are typically mild and resolve within a few days. Rare side effects may include the formation of small lumps under the skin, which practitioners can minimize with proper injection techniques and post-treatment massage.
Clinicians can combine Lanluma with other treatments such as hyaluronic acid fillers or botulinum toxin injections to further enhance facial rejuvenation. Your practitioner can develop a personalized treatment plan based on your needs and goals.
Non-surgical cosmetic procedures global market report. The Business Research Company website. Accessed April 25, 2025. https://www.thebusinessresearchcompany.com/report/non-surgical-cosmetic-procedures-global-market-report
Dermal fillers market report. Fortune Business Insights website. Accessed April 25, 2025. https://www.fortunebusinessinsights.com/industry-reports/dermal-fillers-market-100939
Products
Cart
Log In
Newsletter
Subscribe for exclusive offers and updates on new arrivals
Share feedback at:
Working Hours
Monday to Friday: 9 AM to 6 PM EST
The Most Popular Brands
Med Supply Solutions
Support
Copyright 2025. Med Supply Solutions